Windtree Therapeutics, Inc. (WINT)
NASDAQ: WINT · Real-Time Price · USD
4.350
-0.450 (-9.38%)
At close: Feb 21, 2025, 4:00 PM
4.460
+0.110 (2.53%)
After-hours: Feb 21, 2025, 7:50 PM EST
Windtree Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Revenue | - | - | - | - | - | 0.2 | |
| Revenue Growth (YoY) | - | - | - | - | - | -88.93% | |
| Cost of Revenue | - | - | - | - | - | 12.69 | |
| Gross Profit | - | - | - | - | - | -12.49 | |
| Selling, General & Admin | 7.92 | 8.7 | 10.79 | 14.47 | 14.04 | 12.4 | |
| Research & Development | 16.94 | 8.14 | 10.7 | 17.79 | 15.37 | - | |
| Operating Expenses | 24.86 | 16.84 | 21.49 | 32.26 | 29.42 | 12.4 | |
| Operating Income | -24.86 | -16.84 | -21.49 | -32.26 | -29.42 | -24.89 | |
| Interest Expense | -0.19 | -0.05 | -0.05 | -0.11 | -0.13 | -0.5 | |
| Interest & Investment Income | 0.12 | 0.33 | 0.11 | 0.09 | 0.12 | 0.15 | |
| Currency Exchange Gain (Loss) | -0.1 | - | 0.7 | -0.3 | -1.2 | -0.5 | |
| Other Non Operating Income (Expenses) | 1.49 | 0.03 | 0 | -0.02 | -1.05 | 0.05 | |
| EBT Excluding Unusual Items | -23.53 | -16.53 | -20.73 | -32.6 | -31.67 | -25.68 | |
| Merger & Restructuring Charges | -0.7 | -0.7 | - | - | - | - | |
| Impairment of Goodwill | - | -3.06 | -12.62 | - | - | - | |
| Asset Writedown | - | - | -7.22 | -45.02 | - | - | |
| Other Unusual Items | 14.59 | - | - | - | -0.9 | -1.79 | |
| Pretax Income | -9.64 | -20.29 | -40.58 | -77.62 | -32.57 | -27.48 | |
| Income Tax Expense | 0.07 | - | -1.37 | -9.99 | - | - | |
| Net Income | -9.71 | -20.29 | -39.21 | -67.64 | -32.57 | -27.48 | |
| Preferred Dividends & Other Adjustments | 1 | - | - | - | - | - | |
| Net Income to Common | -10.71 | -20.29 | -39.21 | -67.64 | -32.57 | -27.48 | |
| Free Cash Flow | -15.3 | -13.45 | -19.47 | -23.94 | -25.61 | -24.85 | |
| Operating Margin | - | - | - | - | - | -12572.22% | |
| Profit Margin | - | - | - | - | - | -13876.26% | |
| Free Cash Flow Margin | - | - | - | - | - | -12552.53% | |
| EBITDA | -24.68 | -16.76 | -21.36 | -32.07 | -29.25 | -24.7 | |
| D&A For EBITDA | 0.17 | 0.08 | 0.13 | 0.19 | 0.17 | 0.2 | |
| EBIT | -24.86 | -16.84 | -21.49 | -32.26 | -29.42 | -24.89 | |
| Revenue as Reported | - | - | - | - | - | 0.2 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.